Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clemastine fumarate versus placebo in secondary relapsing multiple sclerosis
IRCT20080901001165N40Phase 3Completed
- Sponsor
- Baqiyatallah University of Medical Sciences
- Start
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in multiple sclerosis (MS) comparing Clemastine fumarate with Placebo (2 arms). Primary endpoints: Antibody level changes, Quality of life score and 1 more. Started Jul 2018; status: completed.
02
Drugs
clemastine
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on IRCT20080901001165N40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20080901001165N40.